KSE - Delayed Quote KRW

Samsung Biologics Co.,Ltd. (207940.KS)

770,000.00 -10,000.00 (-1.28%)
At close: April 26 at 3:30 PM GMT+9
All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,666,228,521.44
1,666,228,521.44
953,047,810.08
454,596,217.26
202,090,026.54
Investing Cash Flow
-1,566,305,449.62
-1,566,305,449.62
-3,106,477,133.45
-933,489,190.95
-418,685,827.38
Financing Cash Flow
-635,049,948.36
-635,049,948.36
3,000,080,259.53
496,622,135.64
122,560,118.34
End Cash Position
367,937,365.04
367,937,365.04
890,819,570.65
47,410,383.77
28,850,120.61
Capital Expenditure
-1,105,324,663.01
-1,105,324,663.01
-1,009,225,611.00
-421,151,825.94
-148,566,032.72
Issuance of Capital Stock
--
--
3,200,751,000.00
--
--
Issuance of Debt
803,500,000.00
803,500,000.00
805,653,000.00
698,356,060.00
529,952,000.00
Repayment of Debt
-1,280,840,298.12
-1,280,840,298.12
-937,342,928.12
-190,980,000.00
-401,650,000.00
Free Cash Flow
560,903,858.43
560,903,858.43
-56,177,800.92
33,444,391.32
53,523,993.82
12/31/2020 - 11/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers